期刊文献+

缬沙坦对糖尿病肾病大鼠足细胞自噬的影响 被引量:14

Effects of valsartan on podocyte autophagy in rats with diabetic nephropathy
原文传递
导出
摘要 目的:研究缬沙坦对链脲佐菌素(streptozotocin,STZ)诱导的糖尿病肾病(diabetic nephropathy,DN)大鼠的改善作用,及对大鼠足细胞自噬的影响。方法:雄性SD大鼠30只,随机分正常组、模型组和缬沙坦组(n=10)。腹腔注射STZ复制糖尿病动物模型,成模后每日灌胃(ig)给予缬沙坦20 mg·kg^(-1),12周后检测24 h尿蛋白定量、空腹血糖、血肌酐和尿素氮。PAS染色观察肾小球病理改变,免疫荧光双染观察Nephrin及LC3共染色情况。Western Blot检测Nephrin,LC3和p62蛋白的表达。结果:与模型组相比,缬沙坦组大鼠24 h尿蛋白减少,Nephrin和LC3-Ⅱ蛋白表达上调,p62蛋白表达下调(P<0.05)。结论:缬沙坦可能通过提高自噬水平保护足细胞,降低蛋白尿,从而延缓DN进展。 Objective:To study the effects of valsartan on kidney and podocytes autophagy in rats with diabetic nephropathy(DN). Methods: A total of 30 SD rats were randomly divided into 3 groups,that is, normal group, diabetic group, and valsartan group (n = 10). Diabetic animal were induced by an intraperitoneal injection of STZ. Diabetic rats were given valsartan 20 mg- kg-1 by oral garage once daily for 12 weeks. At the end of experiment, serum glucose, creatinine and urea nitrogen were measured. 24-hour urinary specimens were collected for determining albumin. The kidneys were taken out and renal pathological changes were observed after PAS staining. LC3 and P62 protein, as autophagy markers, as well as nephrin were detected by Western blotting. Immunofluorescence double dye of nephrin and LC3 was used to detect the autophagy of podocytes. Results: Compared with the diabetic model group,valsartan ameliorated glomerular pathological changes, raised the protein expression of nephrin and LC3- II , and decreased the expression of P62 ( P 〈 0.05 ). Conclusion : Valsartan has protective effect on the kidney of DN rats, which may be related to its effect of promoting podocyte autophagy.
出处 《中国新药杂志》 CAS CSCD 北大核心 2018年第2期184-189,共6页 Chinese Journal of New Drugs
基金 国家自然科学基金资助项目(81660615) 云南省基金重点项目(2017FE467-004)
关键词 缬沙坦 自噬 足细胞 糖尿病肾病 valsartan autophagy podocytes diabetic nephropathy
  • 相关文献

参考文献3

二级参考文献26

  • 1孙进,孙勇兵,何仲贵.转运蛋白在药物肝胆转运中的重要作用[J].药学学报,2005,40(8):680-685. 被引量:17
  • 2Dr. M.-L. Gross,A. El-Shakmak,A. Szábó,A. Koch,A. Kuhlmann,K. Münter,E. Ritz,K. Amann.ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy[J].Diabetologia.2003(6)
  • 3F. Bonnet,M. E. Cooper,H. Kawachi,T. J. Allen,G Boner,Z. Cao.Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension[J].Diabetologia.2001(7)
  • 4Doublier S,Salvidio G,Lupia E,Ruotsalainen V,Verzola D,Deferrari G,Camussi G.Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II[].Diabetes.2003
  • 5Aaltonen,P,Luimula,P,Astrom,E.Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy[].Laboratory Investigation.2001
  • 6Wu YG,Lin H,Qi XM,Wu GZ,Qian H,Zhao M,Shen JJ,Lin ST.Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes[].International Journal of Immunopharmacology.2006
  • 7Lewis,E.J.,Hunsicker,L.G.,Clarke,W.R.,Berl,T.,Pohl,M.A.,Lewis,J.B.Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes[].The New England Journal of Medicine.2001
  • 8Anderson S,Rennke HG.Brenner BM: Nifedipine versus fosinopril in uninephrectomized diabetic rats[].Kidney International.1992
  • 9Fujihara,CK,Malheiros,DM,Zatz,R,Noronha,ID.Mycophenolate mofetil attenuates renal injury in the rat remnant kidney[].Kidney International.1998
  • 10Soulis,T,Cooper,ME,Vranes,D,Bucala,R,Jerums,G.Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment[].Kidney International.1996

共引文献33

同被引文献113

引证文献14

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部